Recent Work
-
Comments on the Request for Information on Medicare
Schaeffer Initiative experts submitted a comment letter responding to a recent request for information (RFI) related to the Medicare Advantage (MA) program
Categorized in -
To Prevent Public Health Crises, We Need to Update the Essential Medical Product List
Brookings Schaeffer Initiate for Health Policy experts rights that policymakers should create a list of critically important products to avoid supply chain shortages.
Categorized in -
The FDA Could Do More to Promote Generic Competition: Here’s How
USC-Brookings Schaeffer Initiative experts focus on three areas of FDA authority that could be refined to better promote generic competition: the Citizen Petition mechanism; the approval of so-called complex generic drugs; and the phenomenon known as “parking” under the Hatch-Waxman Act.
Categorized in -
Do Time Frames Matter in Self-Report Research?
The choice of time frame in questionnaires can vary considerably and impact the findings.
Categorized in